Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Aryl Hydrocarbon Receptor Connects Inflammation to Breast Cancer
Tiziana Guarnieri
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5264-5264
Open Access | Times Cited: 44

Showing 26-50 of 44 citing articles:

Homologation of the Alkyl Side Chain of Antimitotic Phenyl 4-(2-Oxo-3-alkylimidazolidin-1-yl)benzenesulfonate Prodrugs Selectively Targeting CYP1A1-Expressing Breast Cancers Improves Their Stability in Rodent Liver Microsomes
Atziri Corin Chavez Alvarez, Chahrazed Bouzriba, Emmanuel Moreau, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 4, pp. 2477-2497
Closed Access | Times Cited: 5
Adipocyte-derived kynurenine stimulates malignant transformation of mammary epithelial cells through the aryl hydrocarbon receptor
Jonathan D. Diedrich, Romina Gonzalez-Pons, Hyllana C. D. Medeiros, et al.
Biochemical Pharmacology (2023) Vol. 216, pp. 115763-115763
Open Access | Times Cited: 5
RAB3D, upregulated by aryl hydrocarbon receptor (AhR), promotes the progression of prostate cancer by activating the PI3K/AKT signaling pathway
Jingsong Yu, Haipeng Qi, Zheng Wang, et al.
Cell Biology International (2022) Vol. 46, Iss. 12, pp. 2246-2256
Open Access | Times Cited: 8
Hexachlorobenzene as a differential modulator of the conventional and metronomic chemotherapy response in triple negative breast cancer cells
Yamila Sanchez, M.A. Callejas, Noelia Miret, et al.
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 2, pp. 278-295
Open Access | Times Cited: 1
From Molecules to Microbes: Tracing Cutaneous T-Cell Lymphoma Pathogenesis through Malignant Inflammation
Emily R. Gordon, Lauren M Fahmy, Megan H. Trager, et al.
Journal of Investigative Dermatology (2024) Vol. 144, Iss. 9, pp. 1954-1962
Closed Access | Times Cited: 1
Serial KinderMiner (SKiM) discovers and annotates biomedical knowledge using co-occurrence and transformer models
Robert J. Millikin, Kalpana Raja, John Steill, et al.
BMC Bioinformatics (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Aryl hydrocarbon receptor: An emerging player in breast cancer pathogenesis and its potential as a drug target (Review)
Cong Chen, Zhiying Wang, Zhihong Liao, et al.
Molecular Medicine Reports (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 3
Unveiling the mechanistic role of the Aryl hydrocarbon receptor in environmentally induced Breast cancer
Prarthana Chatterjee, Satarupa Banerjee
Biochemical Pharmacology (2023) Vol. 218, pp. 115866-115866
Closed Access | Times Cited: 2
Expression of transcription factors involved in epithelial-to-mesenchymal transition of the breast cancer cell line MCF-7 co-cultured with adipose tissue mesenchymal stem cells
Vũ Thị Tiến, Lê Hoàng Đức, Van Ngoc Bui, et al.
Vietnam Journal of Biotechnology (2023)
Open Access | Times Cited: 2
The Participation of the Intrinsically Disordered Regions of the bHLH-PAS Transcription Factors in Disease Development
Marta Kolonko, Vladimir N. Uversky, Beata Greb‐Markiewicz
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 2868-2868
Open Access | Times Cited: 5
The Prognostic Impact of Intratumoral Aryl Hydrocarbon Receptor in Primary Breast Cancer Depends on the Type of Endocrine Therapy: A Population-Based Cohort Study
Helga Tryggvadottir, Emma Sandén, Sofie Björner, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 5
Serial KinderMiner (SKiM) Discovers and Annotates Biomedical Knowledge Using Co-Occurrence and Transformer Models
Robert J. Millikin, Kalpana Raja, John Steill, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Identification of UBFD1 as a prognostic biomarker and molecular target among estrogen receptor-positive breast cancer
Lian Duan, Rui Liu, Xiaoyue Cui, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 686, pp. 149171-149171
Open Access | Times Cited: 1
Toxic Encephalopathy After Dioxin Effects Preceding Clinical and Lethal Breast Cancer or Tumours of Secretory Organs as Pertinent Hazard Following Lacking Prevention?
Rainer Frentzel‐Beyme
(2024), pp. 1-7
Open Access
Biological sex differences in hepatic response to in utero dimethylbenz(a)anthracene exposure
Imaobong Inyang, Hunter E White, Kelsey Timme, et al.
Reproductive Toxicology (2024) Vol. 124, pp. 108553-108553
Closed Access
Anticancer Properties of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Potential Agonists 4-Thiazolidinone-Pyrazoline Hybrids Les-4368 and Les-4370 in Colorectal Adenocarcinoma Cells In Vitro
Edyta Kaleniuk, Serhii Holota, Bartosz Skóra, et al.
Applied Sciences (2024) Vol. 14, Iss. 17, pp. 7692-7692
Open Access
The Participation of the Intrinsically Disordered Regions of the bHLH-PAS Transcription Factors in Disease Development
Beata Greb‐Markiewicz, Marta Kolonko
(2020)
Open Access | Times Cited: 1
Adipocyte-Derived Kynurenine Stimulates Malignant Transformation of Mammary Epithelial Cells Through the Aryl Hydrocarbon Receptor
Jonathan D. Diedrich, Romina Gonzalez-Pons, Hyllana C. D. Medeiros, et al.
(2023)
Closed Access
Differential Effect of ITE on the Aryl Hydrocarbon Receptor Signaling in Breast Cancer Tissue: A Histopathological Study
Zhengdong Li, Xiaolin Cheng, Zhigang Zhuang, et al.
International Journal of Morphology (2023) Vol. 41, Iss. 5, pp. 1348-1356
Open Access
Previous Page - Page 2

Scroll to top